Jet Edge signed an agreement with Cue Health to provide its flight crews and global teams access to real-time COVID-19 molecular self-testing with instant results. It is the first private aircraft operator to adopt the most accurate self-test for COVID-19.
Cue’s breakthrough testing technology allows Jet Edge to further our commitment to the health and safety of our passengers and crews. Rather than relying on ever-changing messages from guideline groups, we are now giving each of our employees their own Cue reader and cartridge for daily testing. Their results are fast and actionable. Knowing who is positive and negative each morning greatly lessens our logistical challenges and keeps our passengers and employees even safer. – Jonah Adler, Chief Commercial Officer of Jet Edge
The Cue test utilizes nucleic acid amplification technology to provide lab-quality COVID-19 test results from any location in 20 minutes. Based on current clinical studies submitted to the FDA, this molecular self-testing can detect all known COVID-19 variants, including Omicron. Cue’s lab results are connected to mobile devices so that critical safety information can be easily accessed. The test can be used on adults and children over 2 years, with or without symptoms.
We are proud to help meet the unique testing needs of Jet Edge. The Cue Health Enterprise Dashboard shares test results through a secure, web-based internal application which gives Jet Edge proprietary, timely analytics to swiftly identify trends and make informed safety decisions. With the widely adaptable Cue solution, we can help alleviate the pressures on local testing providers and healthcare systems. – Chris Achar, Chief Strategy Officer of Cue Health
Be the first to leave a review.